BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9089908)

  • 1. The clinical expression of primary biliary cirrhosis.
    Heathcote J
    Semin Liver Dis; 1997 Feb; 17(1):23-33. PubMed ID: 9089908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.
    Heathcote EJ
    Hepatology; 2000 Apr; 31(4):1005-13. PubMed ID: 10733559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary biliary cirrhosis.
    Dabaghi RE; Lester R
    Am Fam Physician; 1986 May; 33(5):155-65. PubMed ID: 3518374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlation of antimitochondrial antibodies.
    Zuber MA; Recktenwald C
    Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary biliary cirrhosis of the liver].
    Popov MS; Popova IV
    Arkh Patol; 1986; 48(5):81-7. PubMed ID: 2427055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis.
    Sánchez-Muñoz D; Castellano-Megías VM; Romero-Gómez M
    Dig Liver Dis; 2007 Mar; 39(3):262-6. PubMed ID: 17270507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is prevalence of PBC underestimated in patients with systemic sclerosis?
    Norman GL; Bialek A; Encabo S; Butkiewicz B; Wiechowska-Kozlowska A; Brzosko M; Shums Z; Milkiewicz P
    Dig Liver Dis; 2009 Oct; 41(10):762-4. PubMed ID: 19357001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of zinc deficiency to insulin resistance in patients with primary biliary cirrhosis.
    Himoto T; Yoneyama H; Kurokochi K; Inukai M; Masugata H; Goda F; Haba R; Watanabe S; Senda S; Masaki T
    Biol Trace Elem Res; 2011 Dec; 144(1-3):133-42. PubMed ID: 21476007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of autoantibodies in primary biliary cirrhosis.
    Nakamura M
    Semin Liver Dis; 2014 Aug; 34(3):334-40. PubMed ID: 25057956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of autoimmune pancreatitis and primary biliary cirrhosis in a Caucasian patient - a rare cause of cholestasis.
    Wiegand J; Neid M; Kaiser T; Wittekind C; Mössner J; Tillmann HL; Schiefke I
    Z Gastroenterol; 2006 Dec; 44(12):1227-9. PubMed ID: 17163373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ductular expression of autoantigens in primary biliary cirrhosis.
    Joplin R; Gershwin ME
    Semin Liver Dis; 1997 May; 17(2):97-103. PubMed ID: 9170196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No prognostic significance of antimitochondrial antibody profile testing in primary biliary cirrhosis.
    Vleggaar FP; van Buuren HR
    Hepatogastroenterology; 2004; 51(58):937-40. PubMed ID: 15239218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimitochondrial antibodies in primary biliary cirrhosis.
    Leung PS; Coppel RL; Ansari A; Munoz S; Gershwin ME
    Semin Liver Dis; 1997 Feb; 17(1):61-9. PubMed ID: 9089911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis.
    Zhang FK; Jia JD; Wang BE
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):288-91. PubMed ID: 15138128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis.
    Invernizzi P; Crosignani A; Battezzati PM; Covini G; De Valle G; Larghi A; Zuin M; Podda M
    Hepatology; 1997 May; 25(5):1090-5. PubMed ID: 9141422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholestatic liver diseases and health-related quality of life.
    Younossi ZM; Kiwi ML; Boparai N; Price LL; Guyatt G
    Am J Gastroenterol; 2000 Feb; 95(2):497-502. PubMed ID: 10685757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: an immunohistochemical study.
    Tsuneyama K; Harada K; Yasoshima M; Kaji K; Gershwin ME; Nakanuma Y
    J Pathol; 1998 Oct; 186(2):126-30. PubMed ID: 9924426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of antimitochondrial antibodies].
    Rüegg R; Matter L; Schopfer K; Grob PJ
    Schweiz Med Wochenschr; 1985 Mar; 115(9):290-6. PubMed ID: 3983600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology of primary biliary cirrhosis: the search for the culprit.
    Leung PS; Coppel RL; Gershwin ME
    Semin Liver Dis; 2005 Aug; 25(3):327-36. PubMed ID: 16143948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.